Skip to main content
SpringerLink
Log in

Diabetic Ketoacidosis

Risk Factors and Management Strategies

  • Therapy in Practice
  • Published:
Treatments in Endocrinology

Abstract

Diabetic ketoacidosis (DKA) is the most common hyperglycemic emergency in patients with diabetes mellitus. DKA most often occurs in patients with type 1 diabetes, but patients with type 2 diabetes are susceptible to DKA under stressful conditions, such as trauma, surgery, or infections. DKA is reported to be responsible for more than 100 000 hospital admissions per year in the US, and accounts for 4–9% of all hospital discharge summaries among patients with diabetes. Treatment of patients with DKA uses significant healthcare resources and accounts for 1 out of every 4 healthcare dollars spent on direct medical care for adult patients with type 1 diabetes in the US.

Recent studies using standardized written guidelines for therapy have demonstrated a mortality rate of less than 5%, with higher mortality rates observed in elderly patients and those with concomitant life-threatening illnesses. Worldwide, infection is the most common precipitating cause for DKA, occurring in 30–50% of cases. Urinary tract infection and pneumonia account for the majority of infections. Other precipitating causes are intercurrent illnesses (i.e., surgery, trauma, myocardial ischemia, pancreatitis), psychological stress, and non-compliance with insulin therapy. The triad of uncontrolled hyperglycemia, metabolic acidosis and increased total body ketone concentration characterizes DKA. These metabolic derangements result from the combination of absolute or relative insulin deficiency and increased levels of counter-regulatory hormones (glucagon, catecholamines, cortisol, and growth hormone).

Successful treatment of DKA requires frequent monitoring of patients, correction of hypovolemia and hyperglycemia, replacement of electrolyte losses, and careful search for the precipitating cause. Since the majority of DKA cases occur in patients with a known history of diabetes, this acute metabolic complication should be largely preventable through early detection, and by the education of patients, healthcare professionals, and the general public.

The frequency of hospitalizations for DKA has been reduced following diabetes education programs, improved follow-up care, and access to medical advice. Novel approaches to patient education incorporating a variety of healthcare beliefs and socioeconomic issues are critical to an effective prevention program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Table II
Table III

Similar content being viewed by others

References

  1. Kaufman FR, Halvorson M. The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 1999; 28: 576–82

    PubMed  CAS  Google Scholar 

  2. Graves EJ, Gillium BS. Detailed diagnosis and procedures: National Discharge Survey, 1995. National Center for Health Statistics. Vital Health Stat 13 1997; 130: 133

    Google Scholar 

  3. Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc 1980; 55: 83–8

    PubMed  CAS  Google Scholar 

  4. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117: 551–8

    PubMed  CAS  Google Scholar 

  5. Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44: 790–5

    Article  PubMed  CAS  Google Scholar 

  6. Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999; 22: 1517–23

    Article  PubMed  CAS  Google Scholar 

  7. Balasubramanyam A, Zern JW, Hyman DJ, et al. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999; 159: 2317–22

    Article  PubMed  CAS  Google Scholar 

  8. McFarlane SI, Chaiken RL, Hirsch S, et al. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med 2001; 18: 10–6

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control, Division of Diabetes Translations. Diabetes Surveillance, 1991. Washington, DC: US Government Printing Office, 1992: 635–1150

    Google Scholar 

  10. Fishbein HA. Diabetic ketoacidosis, hyperosmolar nonketotic coma, lactic acidosis and hypoglycemia. In: Harris MI, Hamman RF, editors. Diabetes in America (National Diabetes Group). Washington, DC: US Department of Health and Human Sciences, 1985: XII–1–16

    Google Scholar 

  11. Geiss LS, Herman WH, Goldschmid MG, et al. Surveillance for diabetes mellitus: United States, 1980–1989. MMWR CDC Surveill Summ 1993; 42: 1–20

    PubMed  CAS  Google Scholar 

  12. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278–85

    Article  Google Scholar 

  13. Ellemann K, Soerensen JN, Pedersen L, et al. Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care 1984; 7: 528–32

    Article  PubMed  CAS  Google Scholar 

  14. Wright AD, Hale PJ, Singh BM, et al. Changing sex ratio in diabetic ketoacidosis. Diabet Med 1990; 7: 628–32

    Article  PubMed  CAS  Google Scholar 

  15. Umpierrez GE, Kelly JP, Navarrete JE, et al. Hyperglycemic crises in urban blacks. Arch Intern Med 1997; 157: 669–75

    Article  PubMed  CAS  Google Scholar 

  16. Javor KA, Kotsanos JG, McDonald RC, et al. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 1997; 20: 349–54

    Article  PubMed  CAS  Google Scholar 

  17. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24: 131–53

    Article  PubMed  CAS  Google Scholar 

  18. Moss JM. Diabetic ketoacidosis: effective low-cost treatment in a community hospital. South Med J 1987; 80: 875–81

    Article  PubMed  CAS  Google Scholar 

  19. Wagner A, Risse A, Brill HL, et al. Therapy of severe diabetic ketoacidosis: zero-mortality under very-low-dose insulin application. Diabetes Care 1999; 22(5): 674–7

    Article  PubMed  CAS  Google Scholar 

  20. White NH. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am 2000; 29: 657–82

    Article  PubMed  CAS  Google Scholar 

  21. Basu A, Close CF, Jenkins D, et al. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282–4

    Article  PubMed  CAS  Google Scholar 

  22. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 1992; 40: 1100–4

    PubMed  CAS  Google Scholar 

  23. Scibilia J, Finegold D, Dorman J, et al. Why do children with diabetes die? Acta Endocrinol Suppl (Copenh) 1986; 279: 326–33

    CAS  Google Scholar 

  24. Umpierrez GE, Khajavi M, Kitabchi AE. Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci 1996; 311: 225–33

    Article  PubMed  CAS  Google Scholar 

  25. Rwiza HT, Swai AB, McLarty DG. Failure to diagnose diabetic ketoacidosis in Tanzania. Diabet Med 1986; 3: 181–3

    Article  PubMed  CAS  Google Scholar 

  26. Polonsky WH, Anderson BJ, Lohrer PA, et al. Insulin omission in women with IDDM. Diabetes Care 1994; 17: 1178–85

    Article  PubMed  CAS  Google Scholar 

  27. Rydall AC, Rodin GM, Olmsted MP, et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997; 336: 1849–54

    Article  PubMed  CAS  Google Scholar 

  28. Musey VC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans: I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care 1995; 18: 483–9

    Article  PubMed  CAS  Google Scholar 

  29. Teutsch SM, Herman WH, Dwyer DM, et al. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med 1984; 310: 361–8

    Article  PubMed  CAS  Google Scholar 

  30. Bending JJ, Pickup JC, Keen H. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion: audit of medical care. Am J Med 1985; 79: 685–91

    Article  PubMed  CAS  Google Scholar 

  31. Siperstein MD. Diabetic ketoacidosis and hyperosmolar coma. Endocrinol Metab Clin North Am 1992; 21: 415–32

    PubMed  CAS  Google Scholar 

  32. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000; 29: 683–705

    Article  PubMed  CAS  Google Scholar 

  33. Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 1995; 79: 9–37

    PubMed  CAS  Google Scholar 

  34. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: normal variations in two separate studies. N Engl J Med 1974; 291: 1275–8

    Article  PubMed  CAS  Google Scholar 

  35. DeFronzo RA, Matzuda M, Barret E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994; 2: 209–38

    Google Scholar 

  36. Felig P, Sherwin RS, Soman V, et al. Hormonal interactions in the regulation of blood glucose. Recent Prog Horm Res 1979; 35: 501–32

    PubMed  CAS  Google Scholar 

  37. Gerich JE, Lorenzi M, Bier DM, et al. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism: studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest 1976; 57: 875–84

    Article  PubMed  CAS  Google Scholar 

  38. McGarry JD, Woeltje KF, Kuwajima M, et al. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab Rev 1989; 5: 271–84

    Article  PubMed  CAS  Google Scholar 

  39. Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med 1983; 309: 159–69

    Article  PubMed  CAS  Google Scholar 

  40. van de Werve G, Jeanrenaud B. Liver glycogen metabolism: an overview. Diabetes Metab Rev 1987; 3: 47–78

    Article  PubMed  Google Scholar 

  41. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 1987; 3: 163–83

    Article  PubMed  CAS  Google Scholar 

  42. Robertson RP, Olson LK, Zhang HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 1994; 43(9): 1085–9

    Article  PubMed  CAS  Google Scholar 

  43. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610–30

    Article  PubMed  CAS  Google Scholar 

  44. Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415–31

    PubMed  CAS  Google Scholar 

  45. Giddings SJ, Chirgwin J, Permutt MA. Effects of glucose on proinsulin messenger RNA in rats in vivo. Diabetes 1982; 31: 624–9

    Article  PubMed  CAS  Google Scholar 

  46. Leibowitz G, Melloul D, Yuli M, et al. Defective glucose-regulated insulin gene expression associated with PDX-1 deficiency in the Psammomys obesus model of type 2 diabetes. Diabetes 2001; 50Suppl. 1: S138–9

    Article  PubMed  CAS  Google Scholar 

  47. McGarry JD. Lilly Lecture 1978: new perspectives in the regulation of ketogenesis. Diabetes 1979; 28: 517–23

    PubMed  CAS  Google Scholar 

  48. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49: 395–420

    Article  PubMed  CAS  Google Scholar 

  49. Cook GA, King MT, Veech RL. Ketogenesis and malonyl coenzyme A content of isolated rat hepatocytes. J Biol Chem 1978; 253: 2529–31

    PubMed  CAS  Google Scholar 

  50. Miles JM, Rizza RA, Haymond MW, et al. Effects of acute insulin deficiency on glucose and ketone body turnover in man: evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis. Diabetes 1980; 29: 926–30

    PubMed  CAS  Google Scholar 

  51. Reichard GA, Skutches CL, Hoeldtke RD, et al. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 1986; 35: 668–74

    Article  PubMed  Google Scholar 

  52. Campbell IW, Duncan LJ, Innes JA, et al. Abdominal pain in diabetic metabolic decompensation: clinical significance. JAMA 1975; 233: 166–8

    Article  PubMed  CAS  Google Scholar 

  53. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 675–80

    Article  PubMed  CAS  Google Scholar 

  54. de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994; 37: 75–81

    Article  PubMed  Google Scholar 

  55. Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care 2002; 17: 63–7

    Article  PubMed  Google Scholar 

  56. Jenkins D, Close CF, Krentz AJ, et al. Euglycaemic diabetic ketoacidosis: does it exist? Acta Diabetol 1993; 30: 251–3

    Article  PubMed  CAS  Google Scholar 

  57. Munro JF, Campbell IW, McCuish AC, et al. Euglycaemic diabetic ketoacidosis. BMJ 1973; 2: 578–80

    Article  PubMed  CAS  Google Scholar 

  58. Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 1971; 20: 485–9

    PubMed  CAS  Google Scholar 

  59. Byrne HA, Tieszen KL, Hollis S, et al. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care 2000; 23: 500–3

    Article  PubMed  CAS  Google Scholar 

  60. Alberti KG, Hockaday TD. Rapid blood ketone body estimation in the diagnosis of diabetic ketoacidosis. BMJ 1972; 2: 565–8

    Article  PubMed  CAS  Google Scholar 

  61. Umpierrez GE, DiGirolamo M, Tuvlin JA, et al. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. J Crit Care 2000; 15: 52–9

    Article  PubMed  CAS  Google Scholar 

  62. Umpierrez GE, Watts NB, Phillips LS. Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis. Diabetes Care 1995; 18: 137–8

    PubMed  CAS  Google Scholar 

  63. Winter SD, Pearson JR, Gabow PA, et al. The fall of the serum anion gap. Arch Intern Med 1990; 150: 311–3

    Article  PubMed  CAS  Google Scholar 

  64. Adrogue HJ, Wilson H, Boyd AE, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 1982; 307: 1603–10

    Article  PubMed  CAS  Google Scholar 

  65. Adrogue HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int 1984; 25: 591–8

    Article  PubMed  CAS  Google Scholar 

  66. Kaminska ES, Pourmotabbed G. Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia. Am J Emerg Med 1993; 11: 77–80

    Article  PubMed  CAS  Google Scholar 

  67. Adrogue HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986; 65: 163–72

    CAS  Google Scholar 

  68. Lebovitz HE. Diabetic ketoacidosis. Lancet 1995; 345: 767–72

    Article  PubMed  CAS  Google Scholar 

  69. Slovis CM, Mork VG, Slovis RJ, et al. Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection. Am J Emerg Med 1987; 5: 1–5

    Article  PubMed  CAS  Google Scholar 

  70. VinicorF, Lehrner LM, Karn RC, et al. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med 1979; 91: 200–4

    Google Scholar 

  71. Vantyghem MC, Haye S, Balduyck M, et al. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes. Acta Diabetol 1999; 36: 39–44

    Article  PubMed  CAS  Google Scholar 

  72. Yadav D, Nair S, Norkus EP, et al. Nonspecific hyperamylasemia and hyper-lipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95: 3123–8

    Article  PubMed  CAS  Google Scholar 

  73. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol 2000; 95: 2795–800

    Article  PubMed  CAS  Google Scholar 

  74. Wrenn KD, Slovis CM, Minion GE, et al. The syndrome of alcoholic ketoacidosis. Am J Med 1991; 91: 119–28

    Article  PubMed  CAS  Google Scholar 

  75. Bleich HL, Boro ES. Metabolic and hepatic effects of alcohol. N Engl J Med 1977; 296: 612–6

    Article  PubMed  CAS  Google Scholar 

  76. Cahill GF. Ketosis. Kidney Int 1981; 20: 416–25

    Article  PubMed  Google Scholar 

  77. Barrett EJ, DeFronzo RA. Diabetic ketoacidosis: diagnosis and treatment. Hosp Pract (Off Ed) 1984; 19: 89–104

    CAS  Google Scholar 

  78. Cahill GF. Starvation in man. N Engl J Med 1970; 282: 668–75

    Article  PubMed  CAS  Google Scholar 

  79. May ME, Young C, King J. Resource utilization in treatment of diabetic ketoacidosis in adults. Am J Med Sci 1993; 306: 287–94

    Article  PubMed  CAS  Google Scholar 

  80. Waldhausl W, Kleinberger G, Korn A, et al. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 1979; 28: 577–84

    PubMed  CAS  Google Scholar 

  81. Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 1981; 30: 510–8

    PubMed  CAS  Google Scholar 

  82. Kitabchi AE, Fisher JN, Murphy MB, Rumbak MJ. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state. In: Hahn CR, Weir GC, editors. Joslin’s diabetes mellitus. 13th ed. Philadelphia (PA): Lea & Febiger, 1994: 738–770

    Google Scholar 

  83. Pinies JA, Cairo G, Gaztambide S, et al. Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabete Metab 1994; 20: 43–8

    PubMed  CAS  Google Scholar 

  84. Hillman K. Fluid resuscitation in diabetic emergencies: a reappraisal. Intensive Care Med 1987; 13: 4–8

    Article  PubMed  CAS  Google Scholar 

  85. Alberti KG, Hockaday TD, Turner RC. Small doses of intramuscular insulin in the treatment of diabetic “coma”. Lancet 1973; II: 515–22

    Article  Google Scholar 

  86. Burghen GA, Etteldorf JN, Fisher JN, et al. Comparison of high-dose and lowdose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 1980; 3: 15–20

    Article  PubMed  CAS  Google Scholar 

  87. Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: low-dose insulin therapy by various routes. N Engl J Med 1977; 297: 238–41

    Article  PubMed  CAS  Google Scholar 

  88. Page MM, Alberti KG, Greenwood R, et al. Treatment of diabetic coma with continuous low-dose infusion of insulin. BMJ 1974; 2: 687–90

    Article  PubMed  CAS  Google Scholar 

  89. Luzi L, Barrett EJ, Groop LC, et al. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37: 1470–7

    Article  PubMed  CAS  Google Scholar 

  90. Sacks HS, Shahshahani M, Kitabchi AE, et al. Similar responsiveness of diabetic ketoacidosis to low-dose insulin by intramuscular injection and albumin-free infusion. Ann Intern Med 1979; 90: 36–42

    PubMed  CAS  Google Scholar 

  91. Latif K, Umpierrez GE, Stoever J, et al. Subcutaneous lispro insulin in the treatment of diabetic ketoacidosis [abstract]. Diabetes 2002; 51Suppl. 2: A427

    Google Scholar 

  92. Abramson E, Arky R. Diabetic acidosis with initial hypokalemia: therapeutic implications. JAMA 1966; 196: 401–3

    Article  PubMed  CAS  Google Scholar 

  93. McCurdy DK. Hyperosmolar hyperglycemic nonketotic diabetic coma. Med Clin North Am 1970; 54: 683–99

    PubMed  CAS  Google Scholar 

  94. DeFronzo RA, Felig P, Ferrannini E, et al. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980; 238: E421–7

    PubMed  CAS  Google Scholar 

  95. Mitchell JH, Wildenthal K, Johnson RL. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1972; 1: 375–89

    Article  PubMed  CAS  Google Scholar 

  96. Housley E, Clarke SW, Hedworth-Whitty RB, et al. Effect of acute and chronic acidaemia and associated hypoxia on the pulmonary circulation of patients with chronic bronchitis. Cardiovasc Res 1970; 4: 482–9

    Article  PubMed  CAS  Google Scholar 

  97. Soler NG, Bennett MA, Dixon K, et al. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet 1972; II: 665–7

    Article  Google Scholar 

  98. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986; 105: 836–40

    PubMed  CAS  Google Scholar 

  99. Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med 1983; 75: 263–8

    Article  PubMed  CAS  Google Scholar 

  100. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983; 57: 177–80

    Article  PubMed  CAS  Google Scholar 

  101. Wilson HK, Keuer SP, Lea AS, et al. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 1982; 142: 517–20

    Article  PubMed  CAS  Google Scholar 

  102. Winter RJ, Harris CJ, Phillips LS, et al. Diabetic ketoacidosis: induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 1979; 67: 897–900

    Article  PubMed  CAS  Google Scholar 

  103. Alberti KG, Emerson PM, Darley JH, et al. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet 1972; II: 391–5

    Article  Google Scholar 

  104. Gibby OM, Veale KE, Hayes TM, et al. Oxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin: oxygen affinity in diabetic ketoacidosis. Diabetologia 1978; 15: 381–5

    Article  PubMed  CAS  Google Scholar 

  105. Kreisberg RA. Phosphorus deficiency and hypophosphatemia. Hosp Pract 1977; 12: 121–8

    PubMed  CAS  Google Scholar 

  106. Kreisberg RA. Diabetic ketoacidosis: an update. Crit Care Clin 1987; 3: 817–34

    PubMed  CAS  Google Scholar 

  107. Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, et al. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 1994; 43: 809–18

    Article  PubMed  CAS  Google Scholar 

  108. Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children [letter]. Lancet 1990; 336: 64

    Article  PubMed  CAS  Google Scholar 

  109. Duck SC, Wyatt DT. Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr 1988; 113: 10–4

    Article  PubMed  CAS  Google Scholar 

  110. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13: 22–33

    Article  PubMed  CAS  Google Scholar 

  111. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis: the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344: 264–9

    Article  PubMed  CAS  Google Scholar 

  112. Silver SM, Clark EC, Schroeder BM, et al. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 1997; 51: 1237–44

    Article  PubMed  CAS  Google Scholar 

  113. Lorber D. Non-ketotic hypertonicity in diabetes. Endocrinologist 1993; 3: 29–38

    Article  Google Scholar 

  114. Beech JS, Williams SR, Cohen RD, et al. Gluconeogenesis and the protection of hepatic intracellular pH during diabetic ketoacidosis in rats. Biochem J 1989; 263: 737–44

    PubMed  CAS  Google Scholar 

  115. Paton RC. Haemostatic changes in diabetic coma. Diabetologia 1981; 21: 172–7

    Article  PubMed  CAS  Google Scholar 

  116. Hamblin PS, Topliss DJ, Chosich N, et al. Deaths associated with diabetic ketoacidosis and hyperosmolar coma 1973–1988. Med J Aust 1989; 151: 439–44

    PubMed  CAS  Google Scholar 

  117. Buyukasik Y, Ileri NS, Haznedaroglu IC, et al. Enhanced subclinical coagulation activation during diabetic ketoacidosis. Diabetes Care 1998; 21: 868–70

    PubMed  CAS  Google Scholar 

  118. Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci 1996; 41: 1–8

    Article  PubMed  CAS  Google Scholar 

  119. Wang LM, Tsai ST, Ho LT, et al. Rhabdomyolysis in diabetic emergencies. Diabetes Res Clin Pract 1994; 26: 209–14

    Article  PubMed  CAS  Google Scholar 

  120. Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic ketoacidosis and hyperglycmic hyperosmolar syndrome. Diabetes Spectrum 2002; 15: 28–36

    Article  Google Scholar 

  121. Laffel LM, Brackett J, Ho J, et al. Changing the process of diabetes care improves metabolic outcomes and reduces hospitalizations. Qual Manag Health Care 1998; 6: 53–62

    PubMed  CAS  Google Scholar 

  122. Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am 2000; 29: 707–23

    Article  PubMed  CAS  Google Scholar 

  123. MacGillivray MH, Li PK, Lee JT, et al. Elevated plasma beta-hydroxybutyrate concentrations without ketonuria in healthy insulin-dependent diabetic patients. J Clin Endocrinol Metab 1982; 54: 665–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Tennessee Health Science Center, 951 Court Avenue, Room 340M, Memphis, Tennessee, 38163, USA

    Guillermo E. Umpierrez & Abbas E. Kitabchi

Authors
  1. Guillermo E. Umpierrez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abbas E. Kitabchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umpierrez, G.E., Kitabchi, A.E. Diabetic Ketoacidosis. Mol Diag Ther 2, 95–108 (2003). https://doi.org/10.2165/00024677-200302020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024677-200302020-00003

Keywords

Search

Navigation